The company’s new campaign, “Countdown at a Crossroads” featuring TV host Sherri Shepherd, shines a spotlight on how CGM technology can help people living with diabetes improve health outcomes and have a better quality of life.

FreeStyle Libre, the company’s glucose monitoring (CGM) device used mainly by type 1 diabetes patients, brought in sales of about $1.4 billion in the third quarter, up 30.5%, and accounting for nearly 14% of the company’s revenue.

India’s Goa state has warned the local unit of Abbott Laboratories it plans to suspend the manufacturing license of its popular antacid medicine after inspectors flagged contamination risks and sanitization issues at its factory, government documents show.

Today the company reported second-quarter profit above expectations, due to recovery in surgical procedure volumes and demand for its diabetes care devices.

Healthcare company Abbott Laboratories (ABT.N) on Tuesday sued one of its former scientists, accusing him in U.S. court of “secretly downloading” sensitive corporate files containing competitive information about nutrition products.

The U.S. Federal Trade Commission is investigating whether baby-formula makers colluded on bids for attractive state contracts, the Wall Street Journal reported on Wednesday.

The new additions to Abbott’s Diversity in Clinical Trials initiative build on the partnerships, scholarships, and the focus on diversified participants in the company’s own clinical trials during the initiative’s first year.

The agency has cleared the first commercially available laboratory traumatic brain injury (TBI) blood test, making it widely available to hospitals in the United States.

The U.S. Food and Drug Administration (FDA) said on Tuesday it will restructure its food program that was slammed last year for responding too slowly to an outbreak of illness among infants who consumed formula from an Abbott Laboratories production plant.

The multinational healthcare giant recorded overall medical device sales of $3.75 billion, missing analysts’ average estimate of $3.84 billion.